1990-1) BEHROUZ N., DEFOSSEZ A., DELACOURTE A., MAZZUCA M. Cortical ß-amyloid. Nature; 1990, 344: 497.
1990-2) BEHROUZ N., DEFOSSEZ A., DELACOURTE A., MAZZUCA M. Maladie d'Alzheimer: La béta protéine amyloïde A4 est aussi présente dans la substance blanche corticale. C. R. Acad. Sci. Paris; 1990, 310: 539-544.
1990-3) DELACOURTE A. General and dramatic glial reaction in Alzheimer brains. Neurology; 1990, 40: 33-37.
1990-4) DELACOURTE A., FLAMENT S., DEFOSSEZ A. Towards the development of an in vitro study model of Alzheimer-type neurofibrillary degeneration. La Presse Médicale; 1990, 19: 170-173.
1990-5) DELACOURTE A., FLAMENT S., DIBE E.M., HUBLAU P., SABLONNIERE B., HEMON B., SCHERRER V., DEFOSSEZ A. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease: demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol.; 1990, 80: 111-117.
1990-6) FLAMENT S., DELACOURTE A. Tau marker ?. Nature; 1990, 346: 22.
1990-7) FLAMENT S., DELACOURTE A., MANN D.M.A. Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Res.; 1990, 516: 15-19.
1990-8) FLAMENT S., DELACOURTE A., DELAERE P., DUYCKAERTS C., HAUW J.J. Correlation between microscopical changes and Tau 64, 69 biochemical detection in senile dementia of the Alzheimer type. Acta Neuropathol.; 1990, 80: 212-215.
1990-9) FLAMENT S., DELACOURTE A., DEFOSSEZ A. An in vitro model for
the study of the neurofibrillary degeneration of the Alzheimer type. Key
topics in brain research. Alzheimer's
disease. Epidemiology, Neuropathology, Neurochemistry, and
Clinics. eds Maurer K., Riderer P., Beckmann H.; 1990, 39:
123-130.